These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age. Parment PA, Svahn A, Rudén U, Bråkenhielm G, Storsaeter J, Akesson L, Linde A. Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613 [Abstract] [Full Text] [Related]
4. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life. Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P. Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190 [Abstract] [Full Text] [Related]
5. Measles, Mumps, and Rubella Serostatus and Response to MMR Vaccination Among HIV-Infected Adults. Singh HK, Chiu YL, Wilkin T. AIDS Patient Care STDS; 2015 Sep; 29(9):461-4. PubMed ID: 26153909 [No Abstract] [Full Text] [Related]
7. Measles, rubella, mumps, and varicella seroprevalence among health care workers in Turkey: is prevaccination screening cost-effective? Celikbas A, Ergonul O, Aksaray S, Tuygun N, Esener H, Tanir G, Eren S, Baykam N, Guvener E, Dokuzoguz B. Am J Infect Control; 2006 Nov; 34(9):583-7. PubMed ID: 17097453 [Abstract] [Full Text] [Related]
9. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid]. Gil Miguel A, Astasio Arbiza P, Ortega Molina P, Domínguez Rojas V, González López A. An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183 [Abstract] [Full Text] [Related]
13. Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants. Yerkovich ST, Rowe J, Richmond P, Suriyaarachchi D, Heaton T, Hollams E, Ladyman C, Serralha M, Sadowska A, Loh R, Wesselingh SL, Sly PD, Holt PG. Vaccine; 2007 Feb 26; 25(10):1764-70. PubMed ID: 17224218 [Abstract] [Full Text] [Related]
14. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody. Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ, Consistency Lot Study Group for ProQuad. Pediatr Infect Dis J; 2006 Jul 26; 25(7):615-22. PubMed ID: 16804432 [Abstract] [Full Text] [Related]
19. Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save? Alp E, Cevahir F, Gökahmetoglu S, Demiraslan H, Doganay M. J Infect Public Health; 2012 Apr 26; 5(2):127-32. PubMed ID: 22541258 [Abstract] [Full Text] [Related]